Lipoprotein(a) and Cerebral Venous Sinus Thrombosis: A Case and the Evidence

Keywords

laboratory diagnostics - lipoproteins - thrombosis - venous thromboembolism

Informed Consent

Patient permission was obtained to share anonymous case study information.

Publication History

Received: 01 February 2025

Accepted: 06 May 2025

Article published online:
23 May 2025

• References

• 1 Gencer B, Kronenberg F, Stroes ES, Mach F. Lipoprotein(a): the revenant. Eur Heart J 2017; 38 (20) 1553-1560
• 2 Sofi F, Marcucci R, Abbate R, Gensini GF, Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 2007; 120 (08) 728-733
• 3 Dentali F, Gessi V, Marcucci R, Gianni M, Grandi AM, Franchini M. Lipoprotein(a) as a risk factor for venous thromboembolism: a systematic review and meta-analysis of the literature. Semin Thromb Hemost 2017; 43 (06) 614-620
• 4 Gilliland TC, Liu Y, Mohebi R. et al. Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes. J Am Coll Cardiol 2023; 81 (18) 1780-1792
• 5 Kronenberg F, Mora S, Stroes ESG. et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J 2022; 43 (39) 3925-3946
• 6 Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256 (18) 2540-2544
• 7 Ariyo AA, Thach C, Tracy R. Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003; 349 (22) 2108-2115
• 8 Yusuf S, Hawken S, Ounpuu S. et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study. Lancet 2004; 364 (9438) 937-952
• 9 Tsimikas S, Marcovina SM. Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week. J Am Coll Cardiol 2022; 80 (09) 934-946
• 10 Optimal Dx. The Intricacies of Converting Lipoprotein(a) Units: A Detailed Analysis. Accessed July 28, 2023 at: https://www.optimaldx.com/blog/the-intricacies-of-converting-lipoproteina-units-a-detailed-analysis
• 11 McConnell JP, Guadagno PA, Dayspring TD. et al. Lipoprotein(a) mass: a massively misunderstood metric. J Clin Lipidol 2014; 8 (06) 550-553
• 12 Thanassoulis G. Lipoprotein(a): solving the puzzle, deciphering the riddle, unraveling the enigma. Can J Cardiol 2023; 39 (10) 1325-1327
• 13 Deb A, Caplice NM. Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. Clin Cardiol 2004; 27 (05) 258-264
• 14 O'Donoghue ML, Rosenson RS, Gencer B. et al; OCEAN(a)-DOSE Trial Investigators. Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease. N Engl J Med 2022; 387 (20) 1855-1864
• 15 von Depka M, Nowak-Göttl U, Eisert R. et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96 (10) 3364-3368
• 16 Nordestgaard BG, Langsted A. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res 2016; 57 (11) 1953-1975
• 17 Skuza AA, Polak M, Undas A. Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties. J Thromb Thrombolysis 2019; 47 (01) 8-15
• 18 Dangal G, Thapa LB. Cerebral venous sinus thrombosis presenting in pregnancy and puerperium. BMJ Case Rep 2009; 2009: bcr06.2009.2045
• 19 Vuorio A, Kaste M, Kovanen PT. Elevated lipoprotein(a) and cerebral venous sinus thrombosis in COVID-19. J Stroke Cerebrovasc Dis 2021; 30 (10) 105865
• 20 Al-Awwad A, Gordon D, Hershey L. et al. Prevalence and Significance of Multiple Hypercoagulable Conditions in Cerebral Venous Thrombosis: 12 Years of Experience in a Referral Center. In: Conference: 15th World Stroke Congress. Vol 18. Date of Publication; 2023 :2023.
• 21 Curbelo SP, Yorio D, Oliver C, Amigo E, Muxi P. Cerebral venous thrombosis. In: Conference: 24th Biennial International Congress on Thrombosis - EMLTD Congress 2016. Vol 141. Date of Publication; 2016
• 22 Torres M, Schenk A. Lipoprotein (a): does it play a role in pediatric ischemic stroke and thrombosis?. Curr Atheroscler Rep 2023; 25 (06) 299-307
• 23 Nowak-Göttl U, Junker R, Hartmeier M. et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100 (07) 743-748
• 24 Heller C, Heinecke A, Junker R. et al; Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108 (11) 1362-1367
• 25 Young G, Albisetti M, Bonduel M. et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008; 118 (13) 1373-1382